Agmatine for Neuroprotection

Moderate evidence 15 studies

Research suggests that agmatine, a naturally occurring compound derived from the amino acid arginine, demonstrates broad neuroprotective properties across a wide range of preclinical models, including ischemia, traumatic brain injury, spinal cord injury, neurodegenerative diseases such as Parkinson's and Alzheimer's disease, retinal damage, and stress-induced neuronal injury. Studies indicate that these effects appear to arise from agmatine's ability to act through multiple biological mechanisms simultaneously, including blocking NMDA glutamate receptors, inhibiting nitric oxide synthase, activating antioxidant pathways such as Nrf2, reducing inflammatory signaling, and promoting neural cell survival and proliferation, particularly in the hippocampus. The current body of evidence consists almost entirely of animal studies, cell culture experiments, and narrative review articles, with a notable absence of large-scale randomized controlled trials or robust clinical evidence in humans, which limits how directly these findings can be applied to human health outcomes. While the preclinical picture is consistently supportive and researchers across multiple reviews describe agmatine's safety profile as favorable, authors uniformly caution that critical questions around optimal dosing, pharmacokinetics, and translation to human disease remain unresolved, and that clinical trials are still needed before any therapeutic conclusions can be drawn.

Related studies

Citations from PubMed and preprint sources. Match score (0-100) reflects automated search ranking, not clinical appraisal.

Title Type Year Direction Match
Neuroprotective offerings by agmatine. Review 2019 Supports 100
Neuroprotection by agmatine: Possible involvement of the gut microbiome? Review 2023 Supports 95
Accelerated functional recovery and neuroprotection by agmatine after spinal ... Other 2000 Supports 90
Neuroprotective Role of Agmatine in Neurological Diseases. Review 2018 Supports 85
Pharmacological profile of agmatine: An in-depth overview. Review 2024 Supports 80
Relevance of imidazoline receptors and agmatine to psychiatry: a decade of pr... Review 2003 Supports 75
Agmatine, a potential novel therapeutic strategy for depression. Review 2016 Supports 70
Role of agmatine in the application of neural progenitor cell in central nerv... Review 2021 Supports 65
Metabolomic Profiling of Aqueous Humor From Glaucoma Patients Identifies Meta... Other 2025 Supports 60
Agmatine: An Emerging Approach for Neuroprotection in Recurrent Ischemic Stro... Other 2024 Supports 55
Imidazoline receptors, novel agents and therapeutic potential. Review 2006 Supports 50
Agmatine induces Nrf2 and protects against corticosterone effects in hippocam... Other 2015 Supports 45
Neuroprotective and neuromodulatory role of agmatine in mitigating simulated ... Other 2026 Supports 40
Solid-state cultivation-specific agmatine production by Aspergillus oryzae: c... Review 2026 Neutral 35
The Neuroprotective Effects of Agmatine on Parkinson's Disease: Focus on Oxid... Review 2025 Supports 30

← Back to Agmatine

Medical Disclaimer: Noyemi provides information from published research for educational purposes only. This content is not medical advice and does not replace consultation with a qualified healthcare provider. Always consult your doctor before starting, stopping, or changing any supplement regimen, especially if you take medications or have existing health conditions.